New asthma inhaler shows promise in early trial
NCT ID NCT06795906
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 32 times
Summary
This early-stage study tested a new daily inhaler called AZD8630 in 24 adults with asthma who already use medium-to-high dose steroid inhalers and long-acting bronchodilators. The main goals were to check safety and how the drug moves through the body. Participants took the inhaler once daily for two weeks. Results will help decide if larger studies are warranted.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Ahrensburg, 22926, Germany
-
Research Site
Berlin, 10119, Germany
-
Research Site
Mainz, 55128, Germany
Conditions
Explore the condition pages connected to this study.